1. Etiology of super-enhancer reprogramming and activation in cancer
- Author
-
Royce W. Zhou and Ramon E. Parsons
- Subjects
Enhancers ,Super-enhancers ,Cancer ,Extrachromosomal DNA ,Topologically associated domain ,Non-coding mutations ,Genetics ,QH426-470 - Abstract
Abstract Super-enhancers are large, densely concentrated swaths of enhancers that regulate genes critical for cell identity. Tumorigenesis is accompanied by changes in the super-enhancer landscape. These aberrant super-enhancers commonly form to activate proto-oncogenes, or other genes upon which cancer cells depend, that initiate tumorigenesis, promote tumor proliferation, and increase the fitness of cancer cells to survive in the tumor microenvironment. These include well-recognized master regulators of proliferation in the setting of cancer, such as the transcription factor MYC which is under the control of numerous super-enhancers gained in cancer compared to normal tissues. This Review will cover the expanding cell-intrinsic and cell-extrinsic etiology of these super-enhancer changes in cancer, including somatic mutations, copy number variation, fusion events, extrachromosomal DNA, and 3D chromatin architecture, as well as those activated by inflammation, extra-cellular signaling, and the tumor microenvironment.
- Published
- 2023
- Full Text
- View/download PDF